David C. Hohn, Director at CLEVELAND BIOLABS INC (CBLI), bought 1,000 shares at $2.36 ($2K) on 2011-10-04, disclosed to the SEC on 2011-10-06.
Scheduled purchase ($2k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CBLI | BUY | 2012-01-05 | $3K | — | Filing → |